Consultancy To Conduct Data Analysis And Develop The Report For The Dolutegravir Cohort Event Monitoring Survey

DeliverablesKey deliverables from this assignment will include: ?Final Report for the Cohort Event Monitoring survey for Zanzibar?Draft Manuscript for the CEM survey 3.Specific RequirementsLANGUAGE:English Language is requiredRead:Expert knowledgeWrite:Expert knowledgeSpeak:Expert knowledge EDUCATION:Desired: Medical Doctor or Pharmacist with a Master's degree in Public Health, Epidemiology, Regulatory Sciences, or a related field from an accredited/ recognized institute. EXPERIENCE:Essential: •The Consultant must have at least 5-10 years' experience in pharmacovigilance •Relevant work experience and comprehensive knowledge of pharmacovigilance including coordinating and leading such studies.•Demonstrable experience in conducting clinical studies, preferably in Cohort Event Monitoring.•In-depth knowledge of the principles, practices, methods, and techniques of Cohort Event Monitoring for safety surveillance.•Well-versed in regulatory sciences and practices related to medical studies including MedDRA terminologies.•Experience and proficiency in statistical analysis including multivariant analysis. •Excellent report writing skills including experience in developing manuscripts supported by publications one has contributed to. •Analytical and documentation skills, presentation of reports•Fluent in spoken and written English WHO Competencies REQUIRED1.Communicating in a credible and effective way 2.Fostering integration and teamwork3.Producing Results4.Building and promoting partnerships across the organization and beyond5.Respecting and promoting individual and cultural differences. Other Skills ( IT): •Good command of Computer Application Systems4.ASSIGNMENTThis consultancy is at NOC Level 5.TIMELINE AND REPORTINGDuration•The duration of the consultancy is 30 days. The consultancy is expected to begin mid-April 2024 and complete assignment within 30 days. Proprietary Rights •Outputs delivered under this consultancy contract will remain the property of the ZFDA, Ministry of Health, Zanzibar and WHO